Skip to Main Content
I'm looking for

Zlatko Rihter

Zlatko Rihter is a Swedish national and joined Mölnlycke in November 2020 as the President and CEO of Mölnlycke Health Care AB. He has extensive experience from the healthcare sector after having spent more than 20 years within the industry. Prior to joining Mölnlycke, he was President and CEO of Sweden-based CellaVision, a world-leading provider of digital solutions for medical microscopy in the field of hematology, listed on Nasdaq Nordic.

Previous positions include EVP Sales & Marketing at ORIGIO, as well as President GBU Chronic at Gambro and Director Patient Handling Product Division at ArjoHuntleigh.

Barry McBride

Irishman Barry joined Mölnlycke in 2014 and leads our Gloves and Antiseptics business,  as well as the global R&D and medical functions. He has a broad global experience in medical devices and has held senior positions in general management, marketing, R&D and operations based in USA, Asia and Europe. Prior to joining Mölnlycke, Barry was CTO and President EMEA for Teleflex,  he also founded a number of medical device startups which were successfully commercialised.

Susanne Larsson image

Susanne Larsson

Susanne, a Swedish national, joined the executive team in March 2020. Most recently she held the role of Group CFO at Gunnebo – a multinational security company, listed on NASDAQ Stockholm. Before that she spent more than 20 years at the Gothenburg-based SKF group in various financial and strategic leadership positions. Susanne has extensive experience from driving growth and efficiency in global companies, including finance leadership, business control, governance and process development. At Mölnlycke she is responsible for Finance, IT and Business Development functions.

Martin Lexa

Martin joined Mölnlycke in 2016. He has many years of experience in the pharmaceutical and medical devices industry in both mature and emerging markets. Before joining the company, he spent several years within Novartis, first as Head of HR OTC for Europe at Novartis Consumer Health, and then as Head of HR for Europe, Middle East and Africa at Alcon. He also worked at Medtronic for five years, including as VP for Human Resources, Europe, Middle East & Africa and Canada – and at Bristol-Myers Squibb in different national and international HR leadership roles.

Eric De Kesel, Mölnlycker Executive Vice President, Operations

Eric De Kesel

Eric has been with the company since 2002 and has held roles as GM of our factory in Waremme, Belgium, as well as heading up various business units within our commercial organisation. Before taking on his current role, he was President of the Surgical Division.

Kristin Hedlund EVP Legal

Kristin Hedlund

Kristin Hedlund is a Swedish national and joined the Executive team in 2018. Before taking on her current role at Mölnlycke she held a number of positions within DB Schenker. Most recently she served as General Counsel and member of the Board at Schenker AB. 

Kristin has more than twenty years of experience in Legal affairs. At Mölnlycke she is responsible for the Legal function and coordinates compliance-related activities in support of the execution of our strategy.

 

Anders Andersson, Mölnlycke Executive Vice President, OR Solutions

Anders Andersson

Anders is responsible for our focused OR (Operating Room) Solutions organization within the Mölnlycke Procedure Trays, staff clothing and drapes product ranges. Anders has been with the company since 2000. During the years with Mölnlycke he has held various senior roles in Operations, Commercial and R&D. Before taking on his current role, he was Vice President of Global Manufacturing. 

As of October 2017 Anders has been appointed EVP OR Solutions and is a member of the Executive Leadership team.

Rob Claypoole, EVP Commercial

Rob Claypoole

Rob is a US national and joined Molnlycke in March 2017 as President, US. He was previously at Medtronic where he held various leadership roles including Global GM, Soft Tissue Repair and Global GM, Obesity & Metabolic Health. Before Medtronic, Rob held various marketing roles with increasing responsibility at Johnson & Johnson’s Vision Care division.

Our Board

Our board

Mölnlycke Health Care is owned (98%) by Investor AB. We operate under a nine-member board of directors. The board consists of seven independent members, our CEO and one member from Investor AB. The chairman is one of the independent board members.



Contact us
Cookies

Cookies help us deliver our services and provide personalized experiences. You can make your choice for cookies by ticking the options below. If you choose to agree, the cookies will be used for website statistics. You can opt out by clicking on the following link